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ABSTRACT
Objectives: To explore how women with negative
mammography screening results, but who were later
diagnosed with interval breast cancer, reacted when
they observed breast symptoms that could indicate
malignancy in-between screening rounds.
Design: Semistructured individual interviews with
women who have been diagnosed with breast cancer
during mammography screening intervals.
Setting: Two breast diagnostic units covering two
counties in Norway.
Participants: 26 women diagnosed with interval
breast cancer.
Results: Women with a screening negative result react
in two ways when experiencing a possible symptom of
breast cancer. Among 24 women with a self-detected
palpable lesion, 14 sought medical advice immediately.
Their argument was to dispose of potential cancer as
soon as possible. Ten women delayed seeking medical
advice, explaining their delay as a result of practical
difficulties such as holidays, uncertainty about the
symptom, and previous experiences of healthcare
services’ ability to handle diffuse symptoms. Also, a
recent negative mammography scan led some women
to assume that the palpable lesion was benign and
wait for the next screening round.
Conclusions: Participating in mammography
screening may contribute to a postponed reaction to
breast cancer symptoms, although most women acted
rapidly when detecting a palpable breast lesion.
Furthermore, screening participation does not
necessarily increase awareness of breast cancer
symptoms.
INTRODUCTION
Mammography screening aims to provide a
presymptomatic diagnosis of breast cancer.
Nevertheless, interval cancer, which is cancer
ARTICLE SUMMARY
Article focus
▪ Interval breast cancer comprises 28% of cancers
among screened women in Europe.
▪ Women who participate in mammography screen-
ing may delay acting upon breast cancer symp-
toms if they trust screening results to be correct.
▪ We asked women with interval breast cancer
how they had reacted to detecting symptoms of
breast cancer in-between screening rounds.
Key messages
▪ Despite the last mammography screening being
negative, most of the interviewed women inter-
preted lumps as breast cancer symptoms and
sought medical advice rapidly. Some women
defined themselves as delayers despite seeking
medical advice less than 3 months after
symptom presentation.
▪ Only a few women who detected symptoms of
breast cancer in-between screening rounds
delayed seeking medical advice due to a recent
negative screening result in the mammography
screening programme.
▪ Other symptoms than lumps were only acknowl-
edged as cancer symptoms in retrospect.
Screening seems a missed opportunity to inform
women better about breast cancer symptoms.
Strengths and limitations of this study
▪ This qualitative interview study is unique in study-
ing the experiences of women with interval cancer
and how they related their experiences with breast
cancer to mammography screening. A limitation to
the current study is that it is based on women’s
retrospective reports. Self-selection in responding
to the invitation present a selection bias; women
with advanced cancer might not have participated
in the study, and participants may have been more
resourceful than average.
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detected between screening rounds, comprises 28% of
cancers among screened women in Europe.1 Survival
rates for interval cancers have improved during recent
decades2 and it is controversial whether true interval
cancers have less favourable prognosis than screening
detected cancers or breast cancers diagnosed outside a
screening programme.3–5 Rayson et al found poorer sur-
vival in true interval breast cancer compared with
screen-detected cancers. The ﬁndings of adverse prog-
nostic factors like higher grade and stage, receptor nega-
tivity and high mitotic index in true interval cancers
might contribute to poorer survival outcome.6 7 On the
other side, survival rates in the screen-detected groups
are biased (lead and length time bias and overdiagno-
sis), leading to misinterpretation of the true effective-
ness of screening.8 It should not be excluded, however,
that diagnostic delay due to a recent negative mammo-
gram may be an important factor in poorer survival
rates.
Diagnostic delay occurs at many stages of the cancer
detection process.9 We will here concentrate on screen-
ing participants interpretation of bodily changes, and
their help-seeking. Early detection of breast cancer has
been promoted throughout the 20th century, including
women’s responsibility to react upon a palpable breast
lesion.10–12 Nevertheless, recognition of a breast cancer
symptom is not always a straightforward process. Cultural
contexts inﬂuence symptom experiences and bodily
signs become symptoms only after an interpretation that
they are abnormal.9 13 14 The process from the onset of
bodily changes until recognition of a symptom may be
the period of time accounting for the greatest propor-
tion of patient delay.15 16 But even then, interpreting
symptoms as cancer does not automatically lead to
taking action.14 17 18
An argument for mammography screening is that it leads
to earlier breast cancer detection compared with women’s
self-detection. The positive effect mammography may have
on the time of detection must, however, be balanced
against whether patient delay could be induced by the
reassurance given following a negative screening.19 A previ-
ous qualitative study indicates that women trust mammog-
raphy screening to provide true results about their breast
status.20 The question addressed in this article is whether
screening participation interferes with the women’s
symptom interpretation and help-seeking. This study
explores how women with negative mammography screen-
ing results who were later diagnosed with interval breast
cancer, reacted when they observed breast symptoms that
could indicate malignancy in-between screening rounds.
METHODS
This was a qualitative interview study with women who
had experienced interval breast cancer within the
Norwegian breast cancer screening programme. This is
a nationwide, public screening programme that offers
mammography biennially for all women aged 50–69.
The study was approved by the Regional Committee for
Medical Research; participation was based on written
consent.
Recruitment
Forty women diagnosed with interval cancer at two hos-
pitals in Central and Northern Norway were invited to
the study. During the years 2006–2009, 173 interval
breast cancers were diagnosed at these two hospitals.
Due to long distances and the low population density in
rural Norway, all invited to the study lived in or near
urban or semiurban areas. In order to have the women’s
stories as close to the event as possible, they were the
20 women last diagnosed with interval breast cancer at
each hospital, living in or nearby one of four cities
(inhabitants 9500–150 000), counting back from
6 months before the study invitation was sent. A total of
26 women accepted the invitation. Due to conﬁdentiality
regulations, we have no access to information about the
14 women who did not respond to the invitation.
Interviews
Semistructured interviews were carried out in 2009 by
the ﬁrst author (MS), at a hospital, a university, a hotel
meeting room, or in the woman’s home or workplace if
requested. Following a semistructured interview guide,
the women were invited to tell their breast cancer story,
including what kind of breast cancer symptoms they had
reacted to. Other questions were about their views on
mammography screening and reactions upon having
interval breast cancer. Each interview lasted 45–60 min,
and was audiotaped prior to being transcribed in verba-
tim. All informants have been given ﬁctitious names to
secure anonymity.
Analysis
Two researchers read all the interviews independently,
and all coauthors read some of the interviews. We used
a method of constant comparison, comparing themes
within and between interviews. All authors discussed
themes arising from the interviews. We conducted the-
matic analysis.21 Data were categorised using NVivo
V.8.0. Within each theme we found subthemes that were
subjected to meaning interpretation.22
RESULTS
Participants
The 26 participating women were aged 53–69 years, in
average 59.4. Twenty-four had discovered the symptoms
of breast cancer themselves; two were detected during
other medical examinations. The women were diag-
nosed with breast cancer between 3 and 23 months after
their last screening mammography and were interviewed
from 6 to 36 months after diagnosis. Based on the
women’s reports during the interview, all had been sur-
gically treated, either with mastectomy or with breast
conserving surgery, 21 women had undergone radiation
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therapy and 14 underwent chemotherapy (table 1). Few
women knew whether their malignant tumour repre-
sented a false-negative mammography scan or a true
interval cancer. Some had asked for a review of previous
images, but most did not mention the possibility of false-
negative screening when asked about their thoughts on
having breast cancer between screening rounds.
Fourteen had contacted the healthcare services within
a week after noticing a palpable lump (table 2). Eight
had waited between 2 weeks and 3 months before
seeking medical advice, and two delayed more than
3 months. There were no differences in type of symptom
between the immediate help-seekers and those waiting
for weeks or months, as all talked about having a lump.
Two women retrospectively reported symptoms such as
mastalgia or breast contour change, but they had not
related this to breast cancer before being diagnosed. In
the following we will present the women’s own explana-
tions for their timing when seeking medical advice.
Seeking medical advice immediately
Those who saw themselves as having sought medical
advice promptly had all called their doctor’s ofﬁce or
the mammography clinic at the ﬁrst opportunity or at
least within a week of feeling a lump.
I detected it at eleven p.m. And there I was, with a
glowing phone at eight a.m. (Laughter) Next morning,
straight to the GP. ( Johanne, 56)
The women who contacted their doctor immediately
had no doubt about the possibility of having cancer. For
them delay was no option after detecting a lump. In
retrospect they had been certain that it could be a
symptom of breast cancer. Thoughts about having
cancer made acting upon it the rational option.
I was very quick to get to the GP. I was certain it was
cancer right away. (…) I became very rational: Go to the
clinic, make it go away. (Vigdis, 62)
Postponing seeking medical advice
Ten of the women had waited between 2 weeks and
6 months before seeking medical advice. Some of the
women reported that they reinterpreted embodied sen-
sations as possible cancer symptoms in retrospect, after
being diagnosed. Prior to feeling a lump, they had
either not noticed these symptoms or at least not inter-
preted them as symptoms of cancer. Each woman gave
several explanations for what she retrospectively saw as
her delay in help-seeking.
Uncertainty about symptom
All these women acknowledged that breast anomalies
could often represent symptoms of breast cancer.
However, their own bodily changes did not always stand
out as deﬁnite symptoms. Being uncertain about the
aetiology of the breast change, it was initially interpreted
as imaginary or something that could change back to
normal.
No you can’t date it because you just sense it and con-
sider it, and eventually it grows, so it could maybe have
been a month or so. (…) Yes, because it could potentially
regress. (Cecilie, 67)
Table 1 Description of treatment for breast cancer, self-reported
Treatment Surgery Surgery+radiation Surgery+chemotherapy
Surgery+radiation+
chemotherapy
Age
50–54 0 0 0 3
55–59 2 3 0 6
60–64 0 4 0 4
65–69 2 1 1 0
Sum 4 (15, 4%) 8 (30, 8%) 1 (3, 8%) 13 (50, 0%) Total N=26
Table 2 Description of women who participated in study: age and help-seeking behaviour
Reaction time
Detected though
other medical
examinations 1–2 days Within 2 weeks Less than 2 months
Approx
6 months
Age Mean=59.4
50–54 0 2 0 1 0 3 (11.5%)
55–59 1 5 3 1 1 11 (42.3%)
60–64 0 3 0 5 0 8 (30.8%)
65–69 1 1 0 1 1 4 (15.4%)
Sum 2 (72.7%) 11 (42.3%) 3 (11.5%) 8 (30.8%) 2 (7.7%) Total N=26
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Olaug (63) and Eva (57) explained their lesions due
to sore skin from a tight bra or to an inﬂammation of
some kind, sensations and observations the women later
reinterpreted as possible early symptoms of cancer.
They delayed seeking medical advice as the symptoms
appeared too vague, for instance having an unpleasant
sensation in the breast, nausea or tiredness. Their initial
interpretations of their bodily sensations were framed by
everyday experiences, as aforementioned. In hindsight,
these bodily experiences were acknowledged as breast
cancer symptoms.
Previous experiences
Postponement of help-seeking also occurred after a
bodily sensation was identiﬁed as a potential symptom.
Previous negative experiences with healthcare services
contributed to reluctance towards seeking potentially
unnecessary medical examinations. Those with multiple
experiences with illness and disease were tired of being
in the patient role. Prior negative encounters with
healthcare services following diffuse symptoms resulted
in a threshold against seeking help with diffuse breast
cancer symptoms.
I thought it might be an inﬂammation because I have
had joint inﬂammations before and maybe that could
have spread. And it was sore too. And one isn’t too happy
to go running to the doctor either. I did that all the time
when I was younger, before I was diagnosed with arthritis,
and with all that pain, so I’d rather not go (laughter). I
got so tired when they never could detect what was
wrong with me and I got all kinds of medications which
damaged... (…) So I am glad when I feel healthy and
don’t have to go. (Eva, 57)
Having had frequent visits to the general practitioner
(GP) made some uneasy about being seen as whimper-
ing. This suggests that ‘be a whimperer’ or seeking
healthcare services unnecessary were incoherent with
their identity. Rather than be perceived as hypochon-
driacs, they would delay help-seeking for uncertain
symptoms.
Practical reasons
There were also practical reasons given for delaying
seeking medical advice. Two women already had a
scheduled appointment with their GP when they
detected a lump. Both waited until the appointment
before bringing the lump to the doctor’s attention.
I had an appointment with the GP a few weeks after, so
I waited until then. It was probably nothing anyway.
(Gudrun, 60)
Noticing a lump during holidays also led to a delay in
seeing the doctor. Actions after ﬁnding a lump were not
solely about the lesion, but also about their social situ-
ation. Practical reasons were intertwined with other
explanations such as interpreting the mass as benign or
non-existent.
Mammography screening
For some of the women the essential argument for
delaying was related to having participated in mammog-
raphy screening. Two different time frames were import-
ant for this argument. One was about having had a
negative mammography in the recent past. The other
was about an upcoming mammography. Having recently
had a mammography scan led some to interpret the
newly discovered lump as harmless. Having trusted mam-
mography to detect even non-palpable lumps, some of
the women experienced it as strange that cancer had
not been found at the screening. Petra, for instance,
detected a lesion in April, but delayed acting upon it
until October.
I wonder if it (last mammography screening) wasn’t in
January that year. And that was probably the reason for
my interpretation. Because I thought that when they
hadn’t seen anything then, it could not be anything now.
(Petra, 66)
Being part of a screening programme thus contributed
to some women’s interpretation of bodily signs as not
being breast cancer symptoms. One woman presented a
forward-looking argument for delaying. She had started
to wait for a screening invitation, but after several months
with a growing tumour she called the screening unit
asking for the next screening appointment.
I started to wait for the (mammography) bus that used to
come, but it never came. Right? It was too long to wait,
because I felt this… (…) Yes, because I’m usually called
in. So I called the hospital and asked them when the bus
was due, and they said that it would not come until later
that year, and she asked me if there was something spe-
ciﬁc I had on my mind? So I told her I had pain in a
breast, but that I knew it isn’t any danger when it hurts.
“Go see a doctor”, she said. So I called my GP that day,
and got an appointment the next day. (Inger, 56)
Even when interpreting her lump as potential cancer,
Inger delayed acting on it as she waited for the screening
programme to act. Both women who had waited
6 months before seeking medical advice explained their
delay with their screening participation. This suggests
that some participants place too much trust in the cancer
detection capabilities of the screening programme.
DISCUSSION
From this qualitative interview study we found that 10 of
24 women who had been mammography screening par-
ticipants put off seeking medical advice when detecting
a palpable lump. True interval breast cancer has poorer
survival compared to screen-detected cancers.6 8
Delaying acting on a breast cancer symptom between
screening rounds could potentially decrease survival.
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Medically deﬁned, diagnostic delay is waiting more than
3 months with a symptom before help-seeking. Though
only 2 among these 26 women fell within this deﬁnition, 8
further women who had not acted immediately considered
themselves to have delayed the diagnosis. The four main
reasons for waiting to seek medical advice were uncertainty
about symptom interpretation, practical reasons, previous
negative experiences and being participants of mammog-
raphy screening. In order to self-detect cancer, individuals
must sense a symptom, acknowledge it as such, and take
action to seek medical advice.23 It has hitherto not been
known whether participating in mammography screening
could inﬂuence any of these processes. What was unique in
the present study was that all study participants had been
participants in a mammography screening programme, and
we explored whether screening participation could have
contributed to a diagnostic delay.
Symptom interpretation of breast cancer may cause
patient delay.9 13–15 24 25 Palpable lumps are a well-
known symptom of breast cancer that should induce
seeking medical advice. All women in a Dutch study
associated lumps with breast cancer.9 However, studies
vary in their conclusions about whether having a palp-
able lesion is associated with more or less delay than
non-palpable symptoms.17 26 In the present study, all the
women referred to lumps when asked what had led to
seeking medical advice. Other symptoms known to rep-
resent breast cancer, such as retraction of the nipple or
skin, nipple discharge, skin discolouring or change in
texture, mastalgia, a palpable lump in the axilla or a
changed breast contour, had only been recognised as
breast cancer symptoms after having the cancer diagno-
sis. For these women, participation in mammography
screening might have increased awareness about self-
examination for lumps but had apparently not increased
knowledge of other symptoms.
Delay in seeking medical advice cannot be explained
solely by lack of knowledge.27 All the women knew that a
lump could be a sign of cancer, and yet some delayed
seeking medical help. Patient delay can depend on the
patient’s interpretation of bodily signs as related to
cancer.23 Although they knew in general that a lump
could be a sign of cancer, some of the women did not
immediately make that connection in their own case. As
found in earlier studies, they did not expect to be ill and
their current situation provided alternative explanations
for their bodily experiences.13 The present study indi-
cates that participating in mammography screening may
provide other explanations for bodily signs, since cancer
had not been detected by mammography. Retrospective
interpretations of bodily sensations as symptoms of
breast cancer suggest that some had been reluctant to
trust their own bodily sensations. In this sense, mam-
mography may contribute to medicalisation, leaving
women to trust medical technology over their own
bodily sensations. Another interpretation is that they
were too frightened by the prospect of having cancer to
react to potential symptoms, in which case screening
participation was not so much a contributing factor to
delay as it was an available excuse to avoid contemplat-
ing cancer.
Seeing previous or upcoming mammography screen-
ing as reasons for delaying seeking medical advice about
potential breast cancer suggests that too much trust in a
public screening programme may contribute to delayed
diagnosis. Though only a few women expressed such
arguments, our study demonstrates their existence in the
population. Trusting previous screens to be correct may
have led to non-cancer interpretations of symptoms.
Waiting for the next screening round instead of acting
upon a palpable lump indicates high trust in the correct-
ness of a biennial design.
Delay has been an essential concept throughout breast
cancer history in the USA.12 Cultural studies of breast
cancer have been scarce in Norway, but media cam-
paigns against delayed diagnosis have been implemen-
ted. These women’s delayed actions must be understood
within such a broader cultural context. Discourses
depicting breast cancer as a continuum have dominated
in recent decades, making women’s breasts objects of
constant surveillance both by themselves and by
others.11 With a lack of clearly identiﬁed measures of
primary prevention, surveillance becomes the sole
option for responsible health behaviour. Although 10
women in the present study claimed having delayed
help-seeking, only two women delayed more than
3 months. Those who saw themselves as having delayed
their active response had varied and complex arguments
explaining their (in) actions while women who sought
medical help immediately were certain that they were
doing the right thing.
Although the design of our study does not tell about
the magnitude of the delay problem, it clearly identiﬁes
a problem which deserves closer attention. In line with
conclusions from other studies,28–30 it also points in the
direction of an upgrading of the importance of women’s
self- examinations and of further education regarding
breast cancer symptoms.
Strengths and limitations
This qualitative interview study is unique in studying the
experiences of women with interval cancer and how
they related their experiences with breast cancer to
mammography screening. Being interviewed about
delaying seeking medical advice when detecting symp-
toms that later were diagnosed as cancer could be
discomforting for those feeling guilty about delaying,
leading to answers masking guilt. A limitation to the
current study is that it is based on women’s retrospective
reports. Some had been diagnosed up to 3 years prior to
the interview. Experiences before having cancer may not
be the most important to remember after going through
intensive cancer treatment, and could have been reinter-
preted several times since experiencing them.
Nearly 65% of those invited to the study chose to par-
ticipate. All women with interval cancer within a speciﬁc
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period in these communities were invited, but self-
selection in responding to the invitation present a selec-
tion bias. It is a limitation to the study that we cannot
compare those participating with the 14 non-
respondents. Serious disease might have hindered par-
ticipation. Despite their cancer diagnosis, only 6of the
26 respondents were fully retired. In Norway, less than
50% of the population aged 55–74 were employed in
200531 which indicates that participants in the present
study could have been more resourceful than women on
average. If diagnostic delay is a problem among the
more resourceful segments of the population, it is rea-
sonable to think that it is also present in the population
in general.
We could expect potential cancer symptoms to be
common in the population, as approximately 15% of
the population at any time experience such symptoms.25
Women with symptoms in-between screening rounds
could be classiﬁed into three groups: women who
receive an interval cancer diagnosis, women whose
symptoms are diagnosed as benign, and women who
delayed seeking medical advice until their next screen-
ing round. As only the ﬁrst group were subjects of this
study, more research on symptom interpretation among
screening participants is warranted.
Implications
Conﬁdence in mammography programmes inﬂuences
the interpretation of breast cancer symptoms. Awareness
of symptoms other than lumps must be improved.
Though information leaﬂets provide information about
interval breast cancer, screening participants might not
read leaﬂets thoroughly. Additional information and
reminders during mammography examinations could be
one solution. Previous experiences of vague symptoms
being set aside could lead women to neglect their own
bodily sensations and prefer technology to give answers
to their health status. In this qualitative study we have
explored the women’s own interpretation of help-
seeking for interval breast cancer. Further studies are
required as to whether their choice of actions have
delayed diagnosis in medical terms, according to
tumour characteristics and survival.
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